Chargement en cours...
New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
Chronic hepatitis C virus (HCV) infection causes end-stage liver diseases and hepato cellular carcinoma. In the USA, Canada, and Japan, simeprevir – one of the second-generation HCV NS3/4A protease inhibitors – in combination with peginterferon α-2a or 2b plus ribavirin has recently been approved fo...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4043814/ https://ncbi.nlm.nih.gov/pubmed/24920913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S50170 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|